$Tharimmune (THAR.US)$Reuters· just Tharimmune: Announces Phase 2 Study Plan for TH104 in Patients With Moderate-to-Severe Pruritus Associated With Primary Biliary Cholangitis
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more